CN103784821A - Traditional Chinese medicinal composition for treating diabetic foot - Google Patents

Traditional Chinese medicinal composition for treating diabetic foot Download PDF

Info

Publication number
CN103784821A
CN103784821A CN201210431115.7A CN201210431115A CN103784821A CN 103784821 A CN103784821 A CN 103784821A CN 201210431115 A CN201210431115 A CN 201210431115A CN 103784821 A CN103784821 A CN 103784821A
Authority
CN
China
Prior art keywords
parts
radix
parched
traditional chinese
chinese medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210431115.7A
Other languages
Chinese (zh)
Other versions
CN103784821B (en
Inventor
厉岩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210431115.7A priority Critical patent/CN103784821B/en
Publication of CN103784821A publication Critical patent/CN103784821A/en
Application granted granted Critical
Publication of CN103784821B publication Critical patent/CN103784821B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicinal composition for treating diabetic foot, and belongs to the field of traditional Chinese medicinal compositions. The traditional Chinese medicinal composition is composed of Salvia miltiorrhiza, fried peach seed, Ligusticum wallichii, Radix Astragali, Radix Codonopsis, fried Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, Caulis Sargentodoxae, Radix Scrophulariae, unprepared rehmannia root, white peony root, leech, fried Atractylodes lancea, Radix Paeoniae Rubra, Glabrous Greenbrier Rhizome and licorice root according to a certain weight ratio. The traditional Chinese medicinal composition has the advantages of good curative effect, short treatment course, high cure rate and low cost, and is worthy to be popularized clinically.

Description

A kind of Chinese medicine composition for the treatment of diabetic foot
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for the treatment of diabetic foot.
Background technology
Diabetic foot refers to the destruction that diabetics causes lower limb infection, ulcer and (or) deep tissue due to factors such as diabetic angiopathy and (or) neuropathy and infection.Diabetic foot often shows as xerosis cutis on foot, poor flexibility, and color of the leather is dimmed, numb limbs and tense tendons, perceptual difference, engender twinge, skelalgia after long-time walking, also pain while progressively developing into rest, arteriopalmus weakens or disappears, and serious caused skin ulceration, infection suppurates are even downright bad.Treatment diabetic foot, to put prevention first, is avoided foot damage as possible, and common general treatment means are: strictly control blood glucose, eliminate the risk factor that causes vascular lesion, and as hypertension, hyperlipidemia etc.Use antibiotic to treat for diabetic foot at present, but the antibiotic therapy cycle is long, toxic side effect more; Also have for this sick Chinese medicine, but Chinese medicine formula complexity and onset are slow.
Summary of the invention
The object of the invention is in order to solve above-mentioned technical deficiency, provide good effect, short treating period, cure rate high, a kind of Chinese medicine composition for the treatment of glycosuria foot that cost is low.
The present invention selects Radix Salviae Miltiorrhizae, Semen Persicae (parched), Rhizoma Chuanxiong, the Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched), Spina Gleditsiae, Caulis Sargentodoxae, Radix Scrophulariae, Radix Rehmanniae, the Radix Paeoniae Alba, Hirudo, Rhizoma Atractylodis (parched), Radix Paeoniae Rubra, Rhizoma Smilacis Glabrae, Radix Glycyrrhizae to combine, make each efficacy of drugs produce synergism, there is effect of dredging the meridian, activating blood circulation to dissipate blood stasis, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, current QI and blood, promoting tissue regeneration by astringents, thereby can effectively treat diabetic foot.
Wherein each raw material effect in formula:
Radix Salviae Miltiorrhizae: be the dry root and rhizome of dicotyledon Labiatae salvia Radix Salviae Miltiorrhizae.Bitter in the mouth, slightly warm in nature.Enter the heart, Liver Channel.There is blood circulation promoting and blood stasis dispelling, pain relieving eliminating carbuncle, effect of nourishing blood to tranquillize the mind.Be used for improving microcirculation, promote reparation and the regeneration of tissue, alleviate local congestion, improve blood circulation, shorten healing time.
Semen Persicae (parched): be the dry mature seed of rosaceous plant Fructus Persicae or Prunus davidiana.Bitter in the mouth, sweet, property is flat.GUIXIN, liver, large intestine channel.There is effect of blood circulation promoting and blood stasis dispelling, for vasodilator, suppress blood coagulation and haemolysis, improve blood flow retardance, blood obstacle.
Rhizoma Chuanxiong: be the rhizome of samphire Rhizoma Chuanxiong.Acrid in the mouth, warm in nature.Return liver, gallbladder, pericardium channel.There is blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, effect of wind-expelling pain-stopping.
The Radix Astragali: be the root of leguminous plant Radix Astagali or Radix Astragali.Sweet in the mouth, slightly warm in nature.Return lung, spleen, liver, kidney channel.There is holder skin ulcer granulation promoting, inducing diuresis to remove edema, effect of expelling pus and toxin by strengthening QI, the astragalus polysaccharides in the Radix Astragali can also be used for enhancing immunity.
Radix Codonopsis: be the root of Campanulaceae Radix Codonopsis, element flower Radix Codonopsis, radix codonpsis tangshen, pipe flower Radix Codonopsis, C. subglobosa, C. canescens.Sweet in the mouth, property is flat, micro-acid.Return spleen, lung meridian.Have effect of nourishing blood to promote the production of body fluid, form for suppressing thrombus in vivo, reduce hyperlipemia, expansion peripheral vessels reduces blood pressure.
Rhizoma Atractylodis Macrocephalae (parched): be the rhizome of the feverfew Rhizoma Atractylodis Macrocephalae.Bitter in the mouth, sweet, warm in nature.Return spleen, stomach warp.Have dampness diuretic, effect of strengthening superficial resistance to stop perspiration, for blood sugar lowering, extends clotting time, anticoagulant.
Spina Gleditsiae: be the Spina jujubae of leguminous plant Fructus Gleditsia.Acrid in the mouth, warm in nature.Return lung, Liver Channel.There is promoting blood circulation by removing wind, effect of detumescence and apocenosis.
Caulis Sargentodoxae: be the stem of plants of Lardizabalaceae Caulis Sargentodoxae.Bitter in the mouth, property is flat.Enter liver, large intestine channel.There is dispersing swelling and dissipating binds, effect of vital energy regualting and blood circulation-promoting.
Radix Scrophulariae: be the dry root of dicotyledon Scrophulariaceae Radix Scrophulariae.Sweet in the mouth, hardship, salty; Cold nature.Return lung, stomach, kidney channel.There is effect of clearing away heat and cooling blood, for expanding lower limb vascular.
Radix Rehmanniae: be the root of dicotyledon medicine scrophulariaceae rehmannia glutinosa plant or bosom celebrating Radix Rehmanniae.Sweet-bitter flavor, cool in nature.Enter the heart, liver, kidney channel.There is effect of clearing away heat and cooling blood, for promoting blood coagulation, reducing blood glucose.
The Radix Paeoniae Alba: be the root of dicotyledon medicine ranunculaceae plant Radix Paeoniae (cultigen).Bitter in the mouth acid, cool in nature.Enter liver, spleen channel.There is the pain relieving of nourishing blood, clear and coherent blood vessels, effect of subduing inflammation.
Hirudo: be being dried all of Hirudinidae animal Hirudo, Hirudo or whitmania acranulata Whitman.Salty in the mouth, hardship, property is flat, nontoxic.Return Liver Channel.There is effect of blood stasis dispelling blood, for suppressing thrombosis.
Rhizoma Atractylodis (parched): be the dry rhizome of feverfew Atractylodes lancea (Thunb.) DC. or Atractylis chinensis, acrid in the mouth, hardship, warm in nature.Return spleen, stomach, Liver Channel.There is the loose swollen effect of dispeling the wind.
Radix Paeoniae Rubra: be the dry root of ranunculaceae plant Radix Paeoniae Rubra or river Radix Paeoniae Rubra.Bitter in the mouth, cold nature.Return Liver Channel.There is effect of clots absorbing pain relieving, removing heat from blood detumescence, for suppressing thrombosis and platelet aggregation.
Rhizoma Smilacis Glabrae: be the dry rhizome of dicotyledon medicine liliaceous plant smilacis glabra.Slightly sweet flavor, property is flat.Return liver, stomach, spleen channel.There is effect of damp eliminating removing toxic substances.
Radix Glycyrrhizae: be the dry root and rhizome of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..Sweet in the mouth, property is flat.GUIXIN, lung, spleen, stomach warp.There is heat-clearing and toxic substances removing, alleviate effect of toxicity.
Medicine material consumption of the present invention is groped in a large number to sum up through inventor and is drawn, each raw material consumption is for all to have good curative effect in following weight parts scope: Radix Salviae Miltiorrhizae 15-25 part, Semen Persicae (parched) 7-17 part, Rhizoma Chuanxiong 7-17 part, Radix Astragali 40-60 part, Radix Codonopsis 10-20 part, Rhizoma Atractylodis Macrocephalae (parched) 15-25 part, Spina Gleditsiae 20-28 part, Caulis Sargentodoxae 20-28 part, Radix Scrophulariae 10-20 part, Radix Rehmanniae 15-25 part, Radix Paeoniae Alba 10-20 part, Hirudo 5-15 part, Rhizoma Atractylodis (parched) 10-20 part, Radix Paeoniae Rubra 10-20 part, Rhizoma Smilacis Glabrae 15-25 part, Radix Glycyrrhizae 5-13 part.
Its optimum weight proportioning component: 20 parts of Radix Salviae Miltiorrhizaes, 12 parts of Semen Persicae (parched)s, 12 parts of Rhizoma Chuanxiongs, 50 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 24 parts of Spina Gleditsiaes, 24 parts of Caulis Sargentodoxae, 15 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 15 parts of the Radix Paeoniae Albas, 10 parts of Hirudos, 15 parts of Rhizoma Atractylodis (parched), 15 parts of Radix Paeoniae Rubra, 20 parts of Rhizoma Smilacis Glabraes, 9 parts of Radix Glycyrrhizae.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into powder.Specifically these crude drug pulverize mix homogeneously can be made to powder, put into hot water or directly decocting become decoction foot bath.
Medicine of the present invention has effect of dredging the meridian, activating blood circulation to dissipate blood stasis, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, current QI and blood, promoting tissue regeneration by astringents, and good effect, cure rate are high, and cost is low.Through 100 routine system clinical observations, experimental result statistics, patients whose symptoms were less severe only use a course for the treatment of of the present invention, total effective rate 92%, symptom is used two courses for the treatment of, total effective rate 97% compared with severe one.
The specific embodiment
Embodiment mono-, 15 parts of Radix Salviae Miltiorrhizaes, 7 parts of Semen Persicae (parched)s, 7 parts of Rhizoma Chuanxiongs, 40 parts of the Radixs Astragali, 10 parts of Radix Codonopsis, 15 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 20 parts of Spina Gleditsiaes, 20 parts of Caulis Sargentodoxae, 10 parts of Radix Scrophulariaes, 15 parts of Radix Rehmanniae, 10 parts of the Radix Paeoniae Albas, 5 parts of Hirudos, 10 parts of Rhizoma Atractylodis (parched), 10 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Smilacis Glabraes, 5 parts of Radix Glycyrrhizae.
Embodiment bis-, 20 parts of Radix Salviae Miltiorrhizaes, 12 parts of Semen Persicae (parched)s, 12 parts of Rhizoma Chuanxiongs, 50 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 24 parts of Spina Gleditsiaes, 24 parts of Caulis Sargentodoxae, 15 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 15 parts of the Radix Paeoniae Albas, 10 parts of Hirudos, 15 parts of Rhizoma Atractylodis (parched), 15 parts of Radix Paeoniae Rubra, 20 parts of Rhizoma Smilacis Glabraes, 9 parts of Radix Glycyrrhizae.
Embodiment tri-, 25 parts of Radix Salviae Miltiorrhizaes, 17 parts of Semen Persicae (parched)s, 17 parts of Rhizoma Chuanxiongs, 60 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 25 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 28 parts of Spina Gleditsiaes, 28 parts of Caulis Sargentodoxae, 20 parts of Radix Scrophulariaes, 25 parts of Radix Rehmanniae, 20 parts of the Radix Paeoniae Albas, 15 parts of Hirudos, 20 parts of Rhizoma Atractylodis (parched), 20 parts of Radix Paeoniae Rubra, 25 parts of Rhizoma Smilacis Glabraes, 13 parts of Radix Glycyrrhizae.
The clinical statistics data that patient uses medicine of the present invention below:
One, physical data
Accept out-patient's totally 100 examples for medical treatment, wherein male's 64 examples, women's 36 examples, M-F 1.8:1,58 years old mean age.
Two, diagnostic criteria
Tcm diagnosis standard is with reference to " guideline of clinical investigations of traditional Chinese medical science Drugs in Therapy diabetes ".Diabetic foot Syndrome Differentiation of Traditional Chinese Medicine:
Clinical manifestation: acromelic gangrene, black, wound surface exudate is less, and limbs are sent out cool to be afraid of cold, and pain numbness is insensitive, palor, thin white fur of tongue, tongue is dark red, a little less than deep-thready pulse.
Three, using method:
Patient with diabetic feet is put in tub or enamel basin by powder after cleaning by warm water, and foot bath 20~30 minutes when putting into hot water and being cooled to 37 ℃ ~ 39 ℃ can constantly be converted when water is cool and be added boiled water and increase to temperature requiredly, and bubble future trouble foot dries naturally, every day twice, at every turn potion.30 days course for the treatment of.
The scope of application: the present invention is mainly suitable for diabetic foot by the 1-3 level in grading Wagner staging and convalescent period that more than 3 grades actute infection has been controlled.
Taboo item: (1) after meal half an hour unsuitable foot bath, the foot bath time should not exceed half an hour.
(2) foot has infection or bleeding, forbid foot bath.
Four, efficacy assessment standard
Criterion of therapeutical effect is with reference to " diagnosis and treatment of diabetic foot and related complication ".
Cure: gangrenous wound surface heals completely, has formed crust or cicatrix.
Take a turn for the better: gangrenous merocrine secretion thing obviously reduces, gangrene, slough major part come off or part granulation new life, and wound surface significantly dwindles.
Invalid: gangrenous wound surface is without obviously dwindling, and secretions is without obvious minimizing, and gangrene is local without significant change or deterioration.
Five, therapeutic outcome statistics
Figure 505062DEST_PATH_IMAGE002
Wherein: total effective rate=cure rate+improvement rate
Model case and curative effect:
Case one, patient Liu, female, 56 years old, the glucose in urine positive before 2 years, oral antidiabetic drug, before year, pedal skin is pale when lower limb lifting, is aubergine when lower limb are sagging, and foot is sent out cool, and pulsation of foot dorsal artery weakens, and outpatient service is diagnosed as diabetic foot.Through patient, with being intended to continue to coordinate in the situation of oral medicine a course for the treatment of of external foot bath, clinical symptoms disappears completely, does not recur again.
Case two, patient Song, man, 62 years old, suffers from diabetes 7 years.Recently, often there is numb twinge in double-legged toe, meet that cold pain increases the weight of, blackening in toenail, xerosis cutis, poor flexibility on foot, and color of the leather is dimmed, numb limbs and tense tendons, perceptual difference, skelalgia symptom after long-time walking.Continuing to coordinate oral medicine in the situation that two courses for the treatment of of external foot bath, toe erythrosis profit, clinical symptoms disappears completely, does not recur again.
Case three, patient Zhu, man, 68 years old, suffer from diabetes 10 years, medication treatment 7 years, feels coolness of extremities often, numbness is stepped on Cotton Gossypii sense, lower limbs edema, pruritus, twinge on foot.Continuing to coordinate oral medicine in the situation that a course for the treatment of of external foot bath, symptom is obviously improved, and continues a course for the treatment of of external, and clinical symptoms disappears completely, does not recur again.

Claims (2)

1. a Chinese medicine composition for the treatment of diabetic foot, is characterized in that, this Chinese medicine composition is the ingredients by following weight portion:
Radix Salviae Miltiorrhizae 15-25 part, Semen Persicae (parched) 7-17 part, Rhizoma Chuanxiong 7-17 part, Radix Astragali 40-60 part, Radix Codonopsis 10-20 part, Rhizoma Atractylodis Macrocephalae (parched) 15-25 part, Spina Gleditsiae 20-28 part, Caulis Sargentodoxae 20-28 part, Radix Scrophulariae 10-20 part, Radix Rehmanniae 15-25 part, Radix Paeoniae Alba 10-20 part, Hirudo 5-15 part, Rhizoma Atractylodis (parched) 10-20 part, Radix Paeoniae Rubra 10-20 part, Rhizoma Smilacis Glabrae 15-25 part, Radix Glycyrrhizae 5-13 part.
2. according to the Chinese medicine composition of the treatment diabetic foot described in claims 1, it is characterized in that, this Chinese medicine composition is the ingredients by following weight portion:
20 parts of Radix Salviae Miltiorrhizaes, 12 parts of Semen Persicae (parched)s, 12 parts of Rhizoma Chuanxiongs, 50 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 24 parts of Spina Gleditsiaes, 24 parts of Caulis Sargentodoxae, 15 parts of Radix Scrophulariaes, 20 parts of Radix Rehmanniae, 15 parts of the Radix Paeoniae Albas, 10 parts of Hirudos, 15 parts of Rhizoma Atractylodis (parched), 15 parts of Radix Paeoniae Rubra, 20 parts of Rhizoma Smilacis Glabraes, 9 parts of Radix Glycyrrhizae.
CN201210431115.7A 2012-11-02 2012-11-02 A kind of Chinese medicine composition treating diabetic foot Expired - Fee Related CN103784821B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210431115.7A CN103784821B (en) 2012-11-02 2012-11-02 A kind of Chinese medicine composition treating diabetic foot

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210431115.7A CN103784821B (en) 2012-11-02 2012-11-02 A kind of Chinese medicine composition treating diabetic foot

Publications (2)

Publication Number Publication Date
CN103784821A true CN103784821A (en) 2014-05-14
CN103784821B CN103784821B (en) 2016-06-01

Family

ID=50661158

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210431115.7A Expired - Fee Related CN103784821B (en) 2012-11-02 2012-11-02 A kind of Chinese medicine composition treating diabetic foot

Country Status (1)

Country Link
CN (1) CN103784821B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106620001A (en) * 2016-11-29 2017-05-10 汪承武 Traditional Chinese medicine for treating diabetic foots and preparation method thereof
CN107854560A (en) * 2017-12-02 2018-03-30 洪雅县瓦屋山药业有限公司 A kind of medicine for treating diabetes and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101167875A (en) * 2007-10-25 2008-04-30 浙江省中药研究所有限公司 Traditional Chinese medicinal preparation for treating diabetes and its preparing process
CN101229268A (en) * 2007-07-27 2008-07-30 黄素文 Retinervus-smoothing regeneration ointment
CN101648005A (en) * 2008-08-13 2010-02-17 北京和润创新医药科技发展有限公司 Medicinal composition for treating skin injury and ulcer and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101229268A (en) * 2007-07-27 2008-07-30 黄素文 Retinervus-smoothing regeneration ointment
CN101167875A (en) * 2007-10-25 2008-04-30 浙江省中药研究所有限公司 Traditional Chinese medicinal preparation for treating diabetes and its preparing process
CN101648005A (en) * 2008-08-13 2010-02-17 北京和润创新医药科技发展有限公司 Medicinal composition for treating skin injury and ulcer and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106620001A (en) * 2016-11-29 2017-05-10 汪承武 Traditional Chinese medicine for treating diabetic foots and preparation method thereof
CN107854560A (en) * 2017-12-02 2018-03-30 洪雅县瓦屋山药业有限公司 A kind of medicine for treating diabetes and preparation method thereof

Also Published As

Publication number Publication date
CN103784821B (en) 2016-06-01

Similar Documents

Publication Publication Date Title
CN103961659B (en) A kind ofly treat Chinese medicine of Mammary cancer upper limb lymphedema and preparation method thereof
CN104524337A (en) Traditional Chinese medicine for treating dental ulcer
CN104288595A (en) Traditional Chinese medicine decoction for treating erythromelalgia and externally applied paste
CN101204440B (en) Medicine for varicosity
CN102784333B (en) Traditional Chinese medicine composition for curing eczema
CN104306944A (en) Oral medicine for treating varicosities
CN104435449A (en) Pharmaceutical composition for resisting atherosclerosis and application of pharmaceutical composition
CN102885896A (en) Medicine for treating thromboangitis obliterans
CN103784821A (en) Traditional Chinese medicinal composition for treating diabetic foot
CN104771527A (en) Traditional Chinese medicine for treating varicosity
CN104689132A (en) Traditional Chinese medicine composition for treating psoriasis
CN104721591A (en) Traditional Chinese medicine for treating migraine
CN104940886A (en) External preparation for treating seborrheic alopecia and preparing method thereof
CN104971331A (en) Orally-taken externally-applied traditional Chinese medicine composition for treating proliferation of mammary gland and preparation method
CN104352704A (en) Formula of traditional Chinese medicine for curing facial neuritis
CN104547748A (en) Anti-acne drug and preparation method thereof
CN107213360A (en) A kind of Chinese medicine composition for treating heavy myasthenia
CN103536690B (en) Traditional Chinese medicine oral liquid for reducing blood pressure
CN106039240A (en) Traditional Chinese medicine composition for treating mammary fibroadenoma
CN103230480B (en) Traditional Chinese medicine used for treating anal eczema caused by blood deficiency and wind evil formation
CN103316246B (en) Chinese medicine composition for treating menorrhagia
CN103845594A (en) Traditional Chinese medicine decoction for treating rheumatic heart disease
CN103263577B (en) Medicine composition for treating psoriasis
CN106109942A (en) A kind of medicine treating hydrothorax
CN105125836A (en) Decoction medicament for treating erythema nodosum and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160601

Termination date: 20161102